Matrixyl
Matrixyl
Matrixyl
Matrixyl
Matrixyl
Matrixyl
Matrixyl
Matrixyl

Matrixyl

£29.00Sold out
Out of stock
Size
ABOUT THIS COMPOUND
Description

Matrixyl (specifically Palmitoyl Pentapeptide-4) from Super Human Peptides UK is a highly advanced, synthetic lipopeptide. It consists of a specific five-amino-acid sequence (Lys-Thr-Thr-Lys-Ser) that is a subfragment of type I collagen, engineered with an attached palmitic acid chain to allow for high lipid solubility and epidermal penetration. In laboratory research, Matrixyl serves as a premier model for investigating profound dermatological repair and extracellular matrix (ECM) remodeling.

Researchers utilize this peptide because it acts as a highly specific biological messenger. When endogenous collagen breaks down, it releases microscopic protein fragments that signal the body to generate new tissue. Matrixyl mimics these fragments, tricking fibroblasts into massively up-regulating the synthesis of collagen (types I, III, and IV), elastin, and fibronectin.

Produced under GMP-compliant conditions and verified for 99% purity or higher, Matrixyl is an essential tool for advanced in-vitro research into skin aging, photodamage recovery, and wound healing.

WarningFor laboratory research use only. Not for human consumption.
Key Features
  • Extracellular Matrix Remodeling: Stimulates the profound synthesis of collagen I, III, and IV alongside fibronectin and hyaluronic acid.
  • Lipopeptide Delivery: Engineered with a palmitoyl fatty acid chain to drastically enhance penetration through lipid-based cellular barriers.
  • Fibroblast Activation: Acts as a direct messenger to skin cells to initiate deep structural repair.
  • Retinol Alternative Model: Heavily studied for producing anti-aging and tissue-thickening effects without the inflammatory irritation associated with traditional retinoids.
  • High Purity: 99% purity or higher (verified by HPLC and MS analysis).
  • Quality Standard: GMP / ISO certified manufacturing.
Research Focus
  • Procollagen Synthesis: Measuring the dose-dependent increase in collagen production within cultured human fibroblasts.
  • Epidermal Penetration: Studying the pharmacokinetics of lipopeptides and how the palmitoyl chain facilitates transport across the stratum corneum.
  • Photodamage Recovery: Preclinical models investigating the restoration of skin elasticity and thickness following severe UV-induced degradation.
  • Wound Healing: Researching the accelerated closure of dermal wounds and the prevention of hypertrophic scarring.
  • Synergistic Formulations: Evaluating the compounding effects of combining Matrixyl with other signaling peptides (like GHK-Cu) or structural proteins to maximize tissue regeneration.
Published Research and Study Findings

The core sequence of Matrixyl (KTTKS) was originally identified in 1993 by researchers studying wound healing, who discovered that this specific subfragment of type I procollagen was responsible for signaling the body to produce new extracellular matrix. However, the raw sequence was highly water-soluble and could not penetrate the skin's natural oil barriers. Sederma Corporation revolutionized this by attaching a palmitoyl group, creating a biologically active, highly penetrable lipopeptide.

Laboratory and in-vitro studies utilizing Matrixyl have demonstrated staggering regenerative properties. In controlled assays comparing Matrixyl to Vitamin C and retinol, researchers found that Palmitoyl Pentapeptide-4 induced a significantly higher rate of collagen and fibronectin synthesis. In 3D tissue-engineered skin models, administration of the peptide resulted in a physically thicker, more structurally sound dermal-epidermal junction.

Because it stimulates natural repair pathways without causing cytotoxicity or inflammation, it remains the gold standard in cosmetic peptide modeling.

NoteAll findings are derived from laboratory and non-clinical research settings.
Representative Scientific References
  • 1.Katayama, K. et al., "A pentapeptide from type I procollagen promotes extracellular matrix production," Journal of Biological Chemistry, 1993.
  • 2.Robinson, L.R. et al., "Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin," International Journal of Cosmetic Science, 2005.
  • 3.Gorouhi, F. et al., "Role of topical peptides in preventing or treating aged skin," International Journal of Cosmetic Science, 2009.
  • 4.Schagen, S.K., "Topical peptide treatments with effective anti-aging results," Cosmetics, 2017.
Technical data
Specifications
Purity
≥99%, HPLC verified
Form
Lyophilised white powder
Molecular formula
C39H75N7O10
Molecular weight
802.0 g/mol
SKU
SHP-MATRX-010
Research category
Regeneration
Storage
-20°C, protected from light
Reconstitution
Reconstitute with bacteriostatic water; swirl gently, do not shake
Research use
In-vitro laboratory research only. Not for human consumption.
Common questions
Frequently asked questions
Matrixyl is a synthetic lipopeptide, palmitoyl pentapeptide-4, engineered with a palmitic acid chain for enhanced skin penetration. It is supplied lyophilised at ≥99% purity verified by HPLC and MS.
It is studied for fibroblast signalling and extracellular matrix synthesis, specifically up-regulation of collagen types I, III and IV, elastin and fibronectin in dermatological research models.
Matrixyl (Palmitoyl Pentapeptide-4) is supplied at ≥99% purity, verified by HPLC with mass-spectrometry identity confirmation. Testing is carried out per batch rather than per product line, so the figures on your certificate of analysis relate to the exact lot in your vial.
Store the sealed vial at -20°C, protected from light. Once reconstituted, the solution should be kept refrigerated at 2-8°C, protected from light, and treated as a short-lived working preparation rather than a long-term stock.
Matrixyl (Palmitoyl Pentapeptide-4) is supplied lyophilised. Reconstitute with bacteriostatic water; swirl gently, do not shake, and allow the powder to dissolve fully before use. Direct the solvent down the inside wall of the vial rather than onto the pellet, and record the volume used so working concentrations can be calculated. This applies to in-vitro laboratory work only.
They address different targets. Matrixyl signals fibroblasts to build collagen and elastin, a structural approach. Snap8 works at the neuromuscular junction, competitively inhibiting SNARE complex assembly to attenuate muscle contraction. Studies of expression lines commonly examine both mechanisms side by side.
Yes. A certificate of analysis covering HPLC purity and mass-spectrometry identity is available for every batch of Matrixyl (Palmitoyl Pentapeptide-4). Each vial carries a batch number on its label, and quoting that number lets us send you the certificate that matches the material you hold rather than a generic example.
Matrixyl (Palmitoyl Pentapeptide-4) has the molecular formula C39H75N7O10 and a molecular weight of 802.0 g/mol. Those figures are stated on the certificate of analysis supplied with each batch and are the values researchers use when preparing molar calculations.
Matrixyl (Palmitoyl Pentapeptide-4) ships from the UK to UK research addresses, with tracked dispatch and insulated packaging. It is sold for in-vitro laboratory research only: it is not a medicine, not a supplement, and not for human or veterinary consumption. Orders are accepted on the basis that the buyer is a qualified researcher.